Rutgers The State University of New Jersey-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Rutgers The State University of New Jersey - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013176
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Rutgers The State University of New Jersey (Rutgers) is a research university that offers undergraduate and postgraduate programs, and research in the areas of health sciences. The university provides continuing education for professional and personal advancement. It offers courses in the areas of accounting and information systems, aerospace engineering, Africana studies, agricultural and resource management agents, agricultural, food, and resource economics, environmental sciences, epidemiology, and others. Rutgers operates through its campuses in New Brunswick, Newark, and Camden. The university provides services, solutions, and clinical care for individuals and the local, national, and global communities. Rutgers is headquartered in New Brunswick, New Jersey, the US.

Rutgers The State University of New Jersey – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Rutgers The State University of New Jersey, Medical Devices Deals, 2011 to YTD 2017 9
Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
BioMotiv Forms Joint Venture with Rutgers University 12
Foundation for Innovative New Diagnostics Enters into Agreement with Cepheid and Rutgers 13
Regent Surgical Health Forms Joint Venture With Robert Wood Johnson University Hospital 14
Proteonomix Enters Into Co-Development Agreement With University of Medicine and Dentistry For UMK-121 Technology 15
Licensing Agreements 16
Biohaven Pharma Enters into Licensing Agreement with Rutgers, The State University of New Jersey 16
Aduro BioTech Enters into Licensing Agreement with Memorial Sloan Kettering Cancer Center, Rockefeller University, Rutgers and University of Bonn 18
Biosearch Technologies Enters Into Licensing Agreement With Rutgers University For turboFISH Technology 20
Biosearch Technologies Extends Licensing Agreement With University Of Medicine And Dentistry Of New Jersey For Stellaris RNA FISH Technology 21
WaferGen Biosystems Enters Into Licensing Agreement With Rutgers University For RNA Quality Control Technology 22
Biosearch Technologies Enters Into Licensing Agreement With University of Medicine and Dentistry of New Jersey For Nucleic Acid Probe Technology 23
Rutgers The State University of New Jersey – Key Competitors 24
Rutgers The State University of New Jersey – Key Employees 25
Rutgers The State University of New Jersey – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Joint Venture 27
Recent Developments 28
Strategy And Business Planning 28
Feb 29, 2016: Z53 Therapeutics, A New Oncology Start-Up, Launches to Combat Cancer-Associated Mutation 28
Government and Public Interest 29
Feb 17, 2016: Cancer Study is ‘Paradigm Shift’ in Cause of Tumor Formation 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Key Facts 2
Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Rutgers The State University of New Jersey, Deals By Therapy Area, 2011 to YTD 2017 8
Rutgers The State University of New Jersey, Medical Devices Deals, 2011 to YTD 2017 9
Rutgers The State University of New Jersey, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
BioMotiv Forms Joint Venture with Rutgers University 12
Foundation for Innovative New Diagnostics Enters into Agreement with Cepheid and Rutgers 13
Regent Surgical Health Forms Joint Venture With Robert Wood Johnson University Hospital 14
Proteonomix Enters Into Co-Development Agreement With University of Medicine and Dentistry For UMK-121 Technology 15
Biohaven Pharma Enters into Licensing Agreement with Rutgers, The State University of New Jersey 16
Aduro BioTech Enters into Licensing Agreement with Memorial Sloan Kettering Cancer Center, Rockefeller University, Rutgers and University of Bonn 18
Biosearch Technologies Enters Into Licensing Agreement With Rutgers University For turboFISH Technology 20
Biosearch Technologies Extends Licensing Agreement With University Of Medicine And Dentistry Of New Jersey For Stellaris RNA FISH Technology 21
WaferGen Biosystems Enters Into Licensing Agreement With Rutgers University For RNA Quality Control Technology 22
Biosearch Technologies Enters Into Licensing Agreement With University of Medicine and Dentistry of New Jersey For Nucleic Acid Probe Technology 23
Rutgers The State University of New Jersey, Key Competitors 24
Rutgers The State University of New Jersey, Key Employees 25
Rutgers The State University of New Jersey, Other Locations 26
Rutgers The State University of New Jersey, Subsidiaries 26
Rutgers The State University of New Jersey, Joint Venture 27

★海外企業調査レポート[Rutgers The State University of New Jersey-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Continental AG:戦略・SWOT・企業財務分析
    Continental AG - Strategy, SWOT and Corporate Finance Report Summary Continental AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • National Power Corporation:企業の戦略的SWOT分析
    National Power Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Dah Chong Hong Holdings Ltd (1828):企業の財務・戦略的SWOT分析
    Dah Chong Hong Holdings Ltd (1828) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Promethera Biosciences SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Promethera Biosciences SA (Promethera) is a developer of cell therapy products for the treatment of liver diseases. The company provides products which are developed on its proprietary progenitor cell type. It offers products such as promethera hepastem and promethera hepascreen, among other …
  • FXI, Inc.:企業の戦略的SWOT分析
    FXI, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Ornua Co-operative Limited:企業の戦略・SWOT・財務情報
    Ornua Co-operative Limited - Strategy, SWOT and Corporate Finance Report Summary Ornua Co-operative Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Akers Biosciences Inc (AKER):企業の製品パイプライン分析2018
    Summary Akers Biosciences Inc (ABI) is a medical device company that develops, manufactures and supplies point-of-care screening and testing products. The company provides clinical diagnostics, safety diagnostics, and wellness products. Its products include BreathScan alcohol detectors, CHUBE, METRO …
  • Dassault Systemes SA (DSY):医療機器:M&Aディール及び事業提携情報
    Summary Dassault Systemes SA (Dassault) is a 3D experience company that offers software applications and services. Dassault offers consulting services in the areas of design, deployment, support, training, and engineering services. The company serves various industries including aerospace and defens …
  • MEDITE Cancer Diagnostics Inc (MDIT):企業の財務・戦略的SWOT分析
    MEDITE Cancer Diagnostics Inc (MDIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • GE Healthcare LLC-製薬・医療分野:企業M&A・提携分析
    Summary GE Healthcare LLC (GE Healthcare) a business unit of General Electric Company, is a global medical device provider that designs, develops, manufactures, and distributes diagnostic imaging and clinical systems; products and services for drug discovery, biopharmaceutical manufacturing and cell …
  • Genuine Parts Company (GPC):企業の財務・戦略的SWOT分析
    Genuine Parts Company (GPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Sino Oil and Gas Holdings Ltd (702):企業の財務・戦略的SWOT分析
    Summary Sino Oil and Gas Holdings Ltd (Sino Oil and Gas), formerly Genesis Energy Holdings Ltd, is an oil and gas company that offers production and development of oil properties. The company offers services such as oil and gas exploration, production, distribution, development and supplying service …
  • Analog Devices, Inc.:戦略・SWOT・企業財務分析
    Analog Devices, Inc. - Strategy, SWOT and Corporate Finance Report Summary Analog Devices, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Nuverra Environmental Solutions Inc (NES):企業の財務・戦略的SWOT分析
    Nuverra Environmental Solutions Inc (NES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • American CryoStem Corp (CRYO):医療機器:M&Aディール及び事業提携情報
    Summary American CryoStem Corp (American CryoStem), formerly Advanced Wound Technologies-MidAtlantic LLC is a manufacturer, developer, and marketer of life-enhancing and stem cell technologies. The company offers products such as adipose derived stem cells, tissue collection and transportation produ …
  • Glaukos Corp (GKOS):企業の財務・戦略的SWOT分析
    Summary Glaukos Corp (Glaukos) is an ophthalmic medical device company that research and develops micro technologies to improve glaucoma therapy. The company develops injectable micro-scale therapies to address the complete range of glaucoma disease states and progression. It provides products such …
  • Grinners Catering (Australia) Pty Ltd:企業の戦略・SWOT・財務分析
    Grinners Catering (Australia) Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Grinners Catering (Australia) Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • SpectraScience Inc (SCIE)-医療機器分野:企業M&A・提携分析
    Summary SpectraScience Inc (SpectraScience) is a medical device company, which undertakes the design, development, manufacture and marketing of light-based technology products. The company offers its proprietary WavSTAT Optical Biopsy System to diagnose tissue health optically by using light. This s …
  • Ameritas Mutual Holding Company:企業の戦略的SWOT分析
    Ameritas Mutual Holding Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Presidio Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Presidio Pharmaceuticals Inc (Presidio Pharmaceuticals) is a clinical-stage pharmaceutical company that discovers, develops, and supplies small-molecule antiviral therapeutics. The company’s products include HCV NS5A, protease inhibitor, ravidasvir hydrochloride, NS5B proteins, lead pan-geno …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆